DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Mike Grey will join a panel to discuss the future of venture capital in life sciences investing at a special event hosted by the San Diego Venture Group on September 27 in San Diego, CA.
News | 09. 20. 2012
Mike Grey will join a panel to discuss the future of venture capital in life sciences investing at a special event hosted by the San Diego Venture Group on September 27 in San Diego, CA.
